The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2019 / Feb / In Conversation with Jeanne Thoma of SPI Pharma
Discovery & Development Formulation Sponsored

In Conversation with Jeanne Thoma of SPI Pharma

By James Strachan 02/18/2019 0 min read

Sponsored By

Share

The Medicine Maker's James Strachan met with business leaders and specialists to discuss the latest innovations and trends in pharmaceutical manufacturing.
Here, James speaks with Jeanne Thoma, President and CEO from SPI Pharma.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

More Articles by James Strachan

Recommended

Related Content

Analytical Champions: Sarah O’Keeffe
Development & Clinical Formulation Biopharma
Analytical Champions: Sarah O’Keeffe

November 10, 2026

14 min read

Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients

Strategic Development of Complex Oral Therapies
Formulation Small Molecules Development & Clinical
Strategic Development of Complex Oral Therapies

November 2, 2026

5 min read

Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies

Staying the Course: Sitting Down With Mike Cooke
Biopharma Drug Delivery Development & Clinical
Staying the Course: Sitting Down With Mike Cooke

October 29, 2026

9 min read

AmacaThera Co-Founder and CEO Mike Cooke reflects on the long road from academic discovery to a potential new treatment for post-operative pain

Meeting the Demands of Injectable Drug Delivery
Drug Delivery
Meeting the Demands of Injectable Drug Delivery

October 22, 2026

1 min read

Stevanato Group’s Adam Stops discusses how delivery systems and manufacturing capabilities can keep pace with increasingly complex drug formulations

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: